SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is facing intense community scrutiny and a potential legal investigation as its leveraged bitcoin strategy struggles amid a broader crypto downturn. Investors are actively debating whether the company faces an existential liquidity crunch or if this deep price correction presents a long-term accumulation opportunity for believers in its digital asset model.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors react to a recent SEC filing regarding executive change-of-control agreements, which is fueling speculation of an imminent acquisition. The community is actively discussing an expected clinical trial readout and significant short-squeeze pressure, as the stock faces high borrow fees and trapped short positions.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing significant downward pressure and intense bearish sentiment as investors weigh the impact of leadership changes, including a new CFO appointment, against ongoing concerns about competitive market share, declining sales in key regions, and overall brand performance. The community is sharply divided, with bulls pointing to the company's iconic status and attractive valuation as a long-term opportunity, while bears remain focused on the stock's multi-year structural decline and weak operational execution ahead of upcoming earnings.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors weigh recent volatility against upcoming catalysts, specifically the anticipated European Medicines Agency regulatory decision and the July 1 J-code implementation for Yartemlea. The community is actively debating the significance of recent leadership departures and sales data, with many shareholders dismissing current price swings as manipulative short-term tactics while maintaining a long-term outlook on the drug's commercial adoption.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is drawing significant investor interest and market volatility following the announcement of a $7 billion all-stock deal to acquire Synaptics, a move aiming to bolster the company's position in Physical AI and edge computing. While analysts are divided on the strategic value of the acquisitionwith some highlighting long-term synergy potential in sensing and connectivity and others raising concerns about deal complexitythe community is actively debating the integration risks versus the potential to become a dominant force in AI-enabled hardware.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies is facing a massive sell-off as retail investors express deep frustration over persistent share dilution and the stock's failure to track its underlying Ethereum holdings. Community discourse is highly polarized, with many calling for investigations into management's strategy while bargain-hunters debate whether the current price represents a capitulation bottom or the start of a terminal decline.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is facing significant downward pressure after announcing broad price increases for MacBooks and iPads to offset surging AI-driven memory costs, sparking community debate over whether the brand's ecosystem loyalty can withstand this inflationary move. Investors are currently split between viewing the dip as a strategic margin-protection gift or a sign of potential demand destruction in an increasingly cost-sensitive consumer market.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is trending as investors debate the potential for a rebound, with the community split between those accumulating at lower price levels and others warning of further downside. Sentiment remains polarized, with many looking for catalysts like potential integration into social media payments to drive a move toward higher valuations.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is seeing strong momentum driven by major international defense and infrastructure contracts, including significant Small Modular Reactor deals in Sweden and expanded engine manufacturing partnerships in India. The community is actively discussing these strategic wins as primary catalysts for long-term growth, with many investors maintaining a bullish outlook despite recent volatility surrounding geopolitical tensions and energy markets.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is experiencing significant upward momentum as investors react to positive earnings guidance and a strategic pivot into AI-driven automotive and optical components. The community is actively debating the company's role as a critical supplier for next-generation Co-Packaged Optics (CPO) and AI infrastructure, fueling speculation about potential institutional accumulation and long-term valuation shifts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$INBX $SLS  I would concur that it has one of the best potential for an asymmetrical return I’ve ever seen.
 
The length the Regal clinical trial has gone on is astonishing. AML is such a rapid, ruthless and brutal killer especially if you can’t get a stem cell transplant. 

The fact that this trial has gone on for six years and more than two years after the last patient was enrolled is astonishing if you know anything about AML leukemia, which unfortunately I do. 

No, there are no guarantees in the market, but this is about the best setup in a clinical trial I’ve ever seen.  ￼ I normally don’t size up my bio investments quite this much.

Bulling

The Wolf of Finland

Hbo Fam

Norman Buchanan

Xuan He

Christy Morgan

Chessdoc

ChxseTheMoney20

mike wilson

Rolando Garrett

$SLS  
$SLS is my #1 largest holding in a $1.4 mil portfolio, with the best asymmetrical return potential I have ever seen in my 43 years of investing…  
  
ALL profits from my Special Situation Stocks go into more SLS ...  
  
My #2  holding is $INBX ... They have 2 major assets/platforms: Ozekibart (INBX-109) which may be worth $3-$4 Bil, and INBX-106 which may be worth $5-$6 Bil ... with some people putting a much higher value on each …  
  
Here is the play on $INBX ...  
  
They will sell one of these 2 for BILLIONS and then spin off the other one (and the rest of pipeline) into a new Company .... They have done this EXACT thing in the past !!! ...  
  
Considering that INBX at $90.46 today has a market cap of $1.33 BIL, you can see how RIDICULOUSLY undervalued it is if I am correct in my analysis!!!! ....  
  
I expect sale to occur in next 1-3 months and then followed quickly with the spinoff !!! ...  
  
LIKE if you agree ...  
  
FOLLOW me @Mike22332233 for all the newest updates on my Special Situation Stocks

StockTwits Web

Inhibrx Inc

Mike

StockTwits for iOS

  I would concur that it has one of the best potential for an asymmetrical return I’ve ever seen.
 
The length the Regal clinical trial has gone on is astonishing. AML is such a rapid, ruthless and brutal killer especially if you can’t get a stem cell transplant. 

The fact that this trial has gone on for six years and more than two years after the last patient was enrolled is astonishing if you know anything about AML leukemia, which unfortunately I do. 

No, there are no guarantees in the market, but this is about the best setup in a clinical trial I’ve ever seen.  ￼ I normally don’t size up my bio investments quite this much.